Cointime

Prokaryotics

company

About

Prokaryotics is a biopharmaceutical company focused on the discovery and development of novel antibiotic classes.

  • 1 - 10

Highlights

Total Funding Amount
$2.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.50M
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Prokaryotics is a biopharmaceutical company focused on the discovery and development of novel antibiotic classes that target serious multi-drug resistant bacterial infections. Prokaryotics leverages deep knowledge of bacterial physiology, innovative screening strategies, and scientific excellence necessary to discover and develop new classes of antibiotics targeting outer membrane biogenesis - the fundamental armor erected by bacteria to naturally withstand the effects of antibiotics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.50M
Prokaryotics has raised a total of $2.50M in funding over 2 rounds. Their latest funding was raised on Mar 8, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 8, 2018 Grant $2.50M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Prokaryotics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
Содержание
компания